CommercialCoverageHigh impact
11.01.02s, Cochlear Implantation
Independence Blue Cross·Audiology, ENT (Ear, Nose & Throat)·Medical Policy
Effective date
Sep 8, 2025
We identified it
Jun 19, 2026
Summary
Independence Blue Cross expanded cochlear implant coverage to now include single-sided deafness (unilateral hearing loss) and asymmetric hearing loss in patients age 5+, while removing restrictive replacement criteria and reclassifying SSD/AHL from experimental to medically necessary. This significantly broadens coverage eligibility and simplifies documentation requirements for replacement components.
Action Required
By September 8, 2025: Billing team must update coverage rules in billing system and prior authorization workflows to recognize single-sided deafness (SSD) and asymmetric hearing loss (AHL) as medically necessary indications for cochlear implant implantation (CPT 69930) and related diagnostic codes (92601-92604, 92626). Update templates to reflect new SSD/AHL diagnostic criteria (H90.41, H90.42) and remove requirement for trial of CROS hearing aids for patients with aural atresia or microtia grade 2+. Remove prior authorization denials for replacement of internal/external components (HCPCS L8614-L8621) when previously covered device is non-functional or cannot be repaired. Train billing staff and providers on new age threshold (5 years and above) and new one-month CROS trial requirement. Update superbills and encounter templates. Reference newly added cross-reference policy 05.00.44r for component replacement guidelines. Failure to implement these changes will result in unnecessary claim denials and lost revenue for previously ineligible SSD/AHL candidates.